Skip to main content
. 2019 Nov 11;16(4):933–944. doi: 10.1080/21645515.2019.1682845

Table 3.

Patient characteristics by whether they received the MenB vaccine*.

Characteristic Received MenB Only or Both MenB and MenACWY Vaccines (n = 1521) Received MenACWY Vaccine Only
(n = 858)
P Value
Age, mean (SD), y 17.72 (1.54) 17.47 (1.50) < 0.001
Male 828 (54.4) 443 (51.6) 0.188
Race     0.147
 White/Caucasian 1022 (67.2) 539 (62.8)  
 African American 248 (16.3) 163 (19.0)  
 Asian 136 (8.9) 79 (9.2)  
 Other 79 (5.2) 59 (6.9)  
 Don’t know/not available 36 (2.4) 18 (2.1)  
Ethnicity     0.024
 Hispanic 187 (12.3) 135 (15.7)  
 Non-Hispanic 1252 (82.3) 667 (77.7)  
 Don’t know/not available 82 (5.4) 56 (6.5)  
High school student 795 (52.3) 537 (62.6) < 0.001
College/graduate student 550 (36.2) 202 (23.5) < 0.001
Living arrangement     < 0.001
 Parents 979 (64.4) 671 (78.2)  
 On-campus dorm 324 (21.3) 90 (10.5)  
 Sharing with other students/friends/roommates 107 (7.0) 45 (5.2)  
 Alone 43 (2.8) 31 (3.6)  
 Other 8 (0.5) 0 (0.0)  
 Don’t know 60 (3.9) 21 (2.4)  
Insurance coverage     0.008
 Private/commercial 1056 (69.4) 589 (68.6)  
 Student healthcare plan 111 (7.3) 46 (5.4)  
 Medicaid 274 (18.0) 187 (21.8)  
 Government/VA hospital 36 (2.4) 11 (1.3)  
 No insurance (cash payer) 22 (1.4) 20 (2.3)  
 Other 5 (0.3) 0 (0.0)  
 Don’t know 17 (1.1) 5 (0.6)  
Ever received other vaccines      
 MenACWY 1st dose 1144 (75.2) 826 (96.3) < 0.001
 MenACWY booster dose 1002 (65.9) 685 (79.8) < 0.001
 HPV 1045 (68.7) 540 (62.9) 0.004
 Tdap 1252 (82.3) 787 (91.7) < 0.001
Treated by a frequent MenB prescriber 1250 (82.2) 639 (74.5) < 0.001

HCP = healthcare provider; HPV = human papilloma virus; MenACWY = meningococcal serogroups A, C, W, and Y; MenB = meningococcal serogroup B; Tdap = tetanus, diphtheria, and acellular pertussis; VA = Veterans Affairs.

P values <0.05 are indicated in bold font.

*According to chart review by HCP.

Values are presented as n (%) unless otherwise noted.